Edition:
United States

Edge Therapeutics Inc (EDGE.OQ)

EDGE.OQ on NASDAQ Stock Exchange Global Select Market

9.41USD
15 Dec 2017
Change (% chg)

$0.34 (+3.75%)
Prev Close
$9.07
Open
$9.07
Day's High
$9.47
Day's Low
$9.07
Volume
74,033
Avg. Vol
18,834
52-wk High
$13.37
52-wk Low
$7.44

Latest Key Developments (Source: Significant Developments)

Edge Therapeutics reports qtrly loss per share $‍0.37​
Wednesday, 1 Nov 2017 07:00am EDT 

Nov 1 (Reuters) - Edge Therapeutics Inc :Edge Therapeutics reports third quarter 2017 financial results.Edge Therapeutics Inc - qtrly loss per share $‍0.37​.  Full Article

Edge Therapeutics qtrly loss per share $0.44
Tuesday, 1 Aug 2017 06:30am EDT 

Aug 1 (Reuters) - Edge Therapeutics Inc ::Edge Therapeutics reports second quarter 2017 financial results and continued operational progress.Edge Therapeutics Inc qtrly loss per share basic and diluted $0.44.Q2 earnings per share view $-0.44 -- Thomson Reuters I/B/E/S.  Full Article

Edge Therapeutics enters commercial supply agreement for EG-1962 with Oakwood Laboratories
Thursday, 6 Jul 2017 06:30am EDT 

July 6 (Reuters) - Edge Therapeutics Inc :Edge Therapeutics announces commercial supply agreement for EG-1962 with Oakwood Laboratories.Edge Therapeutics Inc - also entered agreement for initial product launch of EG-1962.Edge Therapeutics Inc - entered supply agreement, amended and restated development agreement with Oakwood Laboratories for manufacturing of EG-1962.  Full Article

Edge Therapeutics Qtrly loss per share $0.42
Wednesday, 3 May 2017 06:30am EDT 

May 3 (Reuters) - Edge Therapeutics Inc ::Edge Therapeutics reports first quarter 2017 financial results and continued operational progress.Qtrly loss per share $0.42.  Full Article

MUNEER SATTER REPORTS 5.8 PCT PASSIVE STAKE IN EDGE THERAPEUTICS AS OF APRIL 19
Tuesday, 25 Apr 2017 10:47am EDT 

April 25 (Reuters) - :MUNEER A SATTER REPORTS 5.8 PERCENT PASSIVE STAKE IN EDGE THERAPEUTICS INC AS OF APRIL 19, 2017 - SEC FILING.  Full Article

Edge Therapeutics files for offering up to 1.8 mln shares
Wednesday, 19 Apr 2017 06:56am EDT 

April 19 (Reuters) - Edge Therapeutics Inc :Edge Therapeutics Inc - files for offering of up to 1.8 million shares of co's common stock in registered direct offering at negotiated price of $10/share.  Full Article

Edge Therapeutics announces $18 mln registered direct offering of common stock
Wednesday, 19 Apr 2017 06:30am EDT 

April 19 (Reuters) - Edge Therapeutics Inc :Edge Therapeutics announces $18 million registered direct offering of common stock.Edge Therapeutics Inc- Entered into subscription agreement for sale of shares of its common stock.Says proceeds from offering will be used to advance pre-commercial activities for EG-1962.Edge Therapeutics Inc- Proceeds from offering will be used to advance pre-commercial activities for EG-1962.Edge Therapeutics Inc - Edge has agreed to sell to investors 1.8 million shares at a purchase price of $10.00 per share with gross proceeds of $18 million.  Full Article

Edge Therapeutics says Albert Marchio II became CFO on an interim basis
Monday, 13 Mar 2017 09:17am EDT 

Edge Therapeutics Inc : Albert N. Marchio II, chief accounting and administrative officer, became Edge's CFO on an interim basis, effective March 10, 2017 . Andrew Einhorn, previously co's CFO, left co effective March 10, 2017 to pursue other interests - sec filing .Edge Therapeutics Inc - Marchio will continue to serve as Edge's chief accounting and administrative officer - sec filing.  Full Article

Edge Therapeutics reports qtrly loss per share $0.33
Thursday, 2 Mar 2017 06:30am EST 

Edge Therapeutics Inc : Edge Therapeutics reports fourth quarter and full year 2016 financial results .Qtrly loss per share $0.33.  Full Article

Edge Therapeutics reports Q2 loss per share $0.33
Wednesday, 3 Aug 2016 06:30am EDT 

Edge Therapeutics Inc :Quarterly loss per share $0.33.  Full Article